ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

FTC Cigarette Test Should Be Broadened, Cancer Panel Finds

December 16, 1994

UICC Grant Programs Available To Support International Activities

April 16, 1976

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014